Cannabis in Climbing: Yosemite Roots & IFSC WADA Rules
Climbing and cannabis: Boulder/Yosemite cultural roots, the *Free Solo* parlance, and IFSC WADA enforcement. Why elite climbers operate in the same WADA in-competition framework as Olympic sports.
IFSC Under WADA
Sport climbing competition at the elite tier — IFSC World Cup, World Championships, Olympic events — operates under the WADA Code. Section S8 of the 2026 Prohibited List applies identically to climbers, ultrarunners, and cyclists: natural and synthetic THC are prohibited in-competition only, with a 150 ng/mL urinary THC-COOH threshold and a 180 ng/mL Decision Limit. CBD is permitted (removed from the list effective January 1, 2018). The in-competition period commences at 11:59 p.m. on the day before competition.
Sport climbing was added to the Olympic programme at Tokyo 2020 (held 2021). From that point forward, Olympic-tier climbers operate under the same WADA framework that has produced the well-known cannabis cases in track-and-field, swimming, and snowboard — Richardson, Phelps, Rebagliati — though no comparably famous IFSC cannabis case has surfaced through the cannabis-AAF disciplinary process to date.
Boulder and Yosemite: The Cultural Roots
Sport climbing's broader cultural roots predate its Olympic framing by decades. The discipline grew out of two principal U.S. scenes: Yosemite big-wall climbing in the 1960s and 1970s, and the Boulder, Colorado sport-climbing and bouldering scene from the 1980s onward. Both scenes have an openly cannabis-tolerant subculture that long predates the post-2018 hemp regulatory opening or the modern athlete-cannabis sponsorship ecosystem. Cannabis use among elite climbers is openly acknowledged in subculture media — documentary coverage, podcast interviews, climbing-magazine profiles — in a way that has no parallel in stick-and-ball professional sports.
The Prevalence Question
⚠️ ⚠️ Emerging No published prevalence data exists for cannabis use in elite-climbing populations. Scoping reviews of athlete cannabis prevalence (Docter et al., Clinical Journal of Sport Medicine, 2020; Ware et al., Substance Abuse: Research and Treatment, 2019) report 6–25% past-year use across mixed elite-athlete samples but do not break out climbing as a specific subdiscipline. Avery Collins's "at least half" estimate for ultrarunners is the most-cited subdiscipline figure in the broader endurance-sports cannabis discussion; no equivalent figure has been produced for climbing.
What is well-documented is the cultural openness of the discipline about cannabis. Free Solo (the 2018 documentary on Alex Honnold's ropeless ascent of El Capitan's Freerider) and the broader climbing-film genre operate in a Yosemite-Boulder subculture where cannabis is openly acknowledged in parlance and conversation. The documentaries themselves do not endorse use; the cultural overlap is documentary context, not topic.
Why Climbing, Specifically
Climbing's relationship with cannabis is structurally similar to the running and cycling overlaps but not identical. The discipline involves prolonged sub-maximal aerobic output (long approach hikes, long routes, multi-day big-wall climbs) interleaved with intense anaerobic effort (single hard moves, hard sequences). The aerobic component places climbers in the same CB1-modulated reward state that runner's-high research documents (Sparling 2003; Raichlen 2012; Fuss et al. PNAS 2015). The geography — Yosemite, Boulder, Joshua Tree, Indian Creek, Smith Rock — sits squarely in cannabis-permissive jurisdictions and has done well before federal hemp reform.
The discipline's social structure also matters. Climbing is heavily camp-based at major destinations: nights at Camp 4 in Yosemite, summer evenings at Boulder's Mount Sanitas, Indian Creek bivvies. The social fabric outside competition is closer to long-form mountain-culture camping than to a stick-and-ball professional locker room. Cannabis use is one of many expressions of that subculture.
Competition vs Recreation: The Discipline Split
Like cycling, climbing has a sharp tier split. The vast majority of climbers — recreational sport-climbers, weekend boulderers, big-wall enthusiasts, alpinists — never face an IFSC drug test in their lives. The cultural openness about cannabis reflects the recreational and subculture tier, where no testing applies. Elite-tier IFSC competitors and Olympic-pathway athletes carry the testing discipline that washout protocols exist to manage. Avery Collins's documented 5-week pre-tested-event protocol is a defensible reference point for IFSC athletes coming from cannabis-permissive jurisdictions.
CBD and Climbing Recovery
CBD's permitted status under WADA since January 1, 2018 has produced a small but visible CBD-product market for climbers focused on overuse-injury management (finger-tendon, elbow, shoulder) and post-session recovery. The same evidence-base limitations that apply across endurance sport apply here: McCartney et al. (Sports Medicine - Open, 2020) found preliminary CBD anxiolysis at 300-600 mg in stress-inducing contexts; Atalay et al. (2019) consolidated the cellular anti-inflammatory mechanism. Limited evidence. For the THC-contamination risk that defines all athlete CBD purchases, see CBD THC Contamination Risk.
Where Climbing Sits
Climbing's cannabis profile is high cultural openness, no rigorous prevalence data, and an Olympic-and-IFSC-tier testing discipline that operates exactly under the same WADA Code as the rest of Olympic sport. For the runner's-high mechanism that links the climbing, running, and cycling cultures, see Runner's High Science; for the broader endurance-sport context, the Culture overview page ties the disciplines together.